Arkolith/Insider Trading/ORKA/Form 4

Dambkowski Carl

DirectorOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.5M
Net Open-Market Flow
-$2.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 12, 2026Sell(S)13K$70.11$882K39K
Jun 11, 2026Sell(S)22K$70.13$1.6M51K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000054) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML